About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AMRS - Amyris| Previous Close | $2.92 | Open | $2.92 |
| Volume | 1.98M | Market Cap | 698.5M |
| Yield | Last Dividend |
| Amyris, Inc. Reports Third Quarter 2020 ... | 11/05/20 |
| EMERYVILLE, Calif., Nov. 5, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Sustainable Health and Clea... | |
| Amyris And Rosie Huntington-Whiteley Ann... | 10/30/20 |
| EMERYVILLE, Calif., Oct. 30, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty ma... | |
| Glancy Prongay & Murray LLP, a Leading S... | 10/23/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $AMRS #CLASSACTION--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyr... | |
| Amyris and Arzeda Enter into Development... | 10/20/20 |
| SEATTLE, Oct. 20, 2020 /PRNewswire/ -- Arzeda, the Protein Design Company???, today announced that the company has entered into a joint development ag... | |
| The Law Offices of Frank R. Cruz Announc... | 10/08/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $AMRS #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors... | |
| Amyris Delivering Sustainable Alternativ... | 10/01/20 |
| EMERYVILLE, Calif., Oct. 1, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty mar... | |
| Amyris' Pipette Clean Baby Brand Selecte... | 09/21/20 |
| EMERYVILLE, Calif., Sept. 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty m... | |
| Amyris Continues Market Adoption Of Its ... | 09/15/20 |
| EMERYVILLE, Calif., Sept. 15, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty m... | |
| Amyris to Provide Business Overview And ... | 09/14/20 |
| EMERYVILLE, Calif., Sept. 14, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty m... | |
| Amyris Denies 'Patent Infringement' Alle... | 09/11/20 |
| Biotech firm Amyris Inc. (NASDAQ: AMRS ) is clapping back at allegations made by Lavvan Inc. that it committed patent infringment. "Amyris is disappoi... | |
| Amyris Responds To LAVVAN's Filing Of La... | 09/11/20 |
| EMERYVILLE, Calif., Sept. 11, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty m... | |
| LAVVAN, Inc. Files $881 Million Federal ... | 09/10/20 |
| NEW YORK, Sept. 10, 2020 /PRNewswire/ -- LAVVAN, Inc. ("LAVVAN") today announced that it has filed an $881 million lawsuit against biotechnology compa... | |
| Amyris to Present at H.C. Wainwright 22n... | 09/08/20 |
| EMERYVILLE, Calif., Sept. 8, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty ma... | |
| Amyris Scales First Fermentation-Based C... | 09/01/20 |
| EMERYVILLE, Calif., Sept. 1, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty ma... | |
| INVESTOR ALERT: Monteverde & Associates ... | 07/29/20 |
| NEW YORK , July 29, 2020 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm hea... | |
| SHAREHOLDER ALERT: WeissLaw LLP Investig... | 07/28/20 |
| NEW YORK, July 28, 2020 /PRNewswire/ -- URGENT: SHAREHOLDER VOTE AUGUST 14, 2020 WeissLaw LLP is investigating possible breaches of fiduciary duty and... | |
| Amyris partners with IDRI to create adju... | 07/27/20 |
| Amyris (AMRS +4.7%) and Infectious Disease Research Institute (IDRI) has signed a binding term for a planned COVID-19 RNA (ribonucleic acid) vaccine t... | |
| Why Amyris Is Trading Higher Today | 07/27/20 |
| Amyris (NASDAQ: AMRS ) shares are trading higher on Monday after the company signed a binding term sheet for a planned COVID-19 RNA vaccine technology... | |
| Amyris and The Infectious Disease Resear... | 07/27/20 |
| EMERYVILLE, Calif. , July 27, 2020 /PRNewswire/ -- Amyris, Inc. (NASDAQ: AMRS ), a leading synthetic biotechnology company in Clean Health and Beauty ... | |
| Amyris To Host Second Quarter 2020 Finan... | 07/23/20 |
| EMERYVILLE, Calif., July 23, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty ma... | |
| INVESTIGATION ALERT: The Schall Law Firm... | 07/16/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $AMRS #AMRS--INVESTIGATION ALERT: The Schall Law Firm Announces It is Investigating Claims Against Amyris, Inc. | |
| Amyris Launches Plant-derived Sustainabl... | 07/15/20 |
| EMERYVILLE, Calif., July 15, 2020 /PRNewswire/ -- Aprinnova, Inc., an Amyris, Inc. (Nasdaq: AMRS) joint venture, the leading supplier of high performa... | |
| Amyris Announces Closing Of $200 Million... | 06/10/20 |
| EMERYVILLE, Calif., June 10, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty ma... | |
| Amyris Raises $200 Million From Private ... | 06/04/20 |
| EMERYVILLE, Calif. , June 4, 2020 /PRNewswire/ -- Amyris, Inc. (NASDAQ: AMRS ), a leading synthetic biotechnology company in Clean Health and Beauty m... | |
| Resgreen Group Invests in Autonomous Mob... | 06/01/20 |
| EASTPOINTE, MI / ACCESSWIRE / June 1, 2020 / Resgreen Group (OTC PINK:RGGI) Resgreen Group (RGGI), a leading mobile robot developer, announced today t... | |
| Amyris Launches Safe Alternative To Talc... | 05/21/20 |
| EMERYVILLE, Calif., May 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty mar... | |
| Amyris Changes its 2020 Annual Meeting o... | 05/15/20 |
| EMERYVILLE, Calif., May 15, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health... | |
| Amyris Inc. (NASDAQ: AMRS) Q1 2020 Earni... | 05/08/20 |
| Amyris Inc. (AMRS) Q1 2020 earnings call dated May 08, 2020 Presentation: Operator Welcome to the Amyris First Quarter 2020 Financial Results Conferen... | |
| Amyris to Participate in the Oppenheimer... | 05/07/20 |
| EMERYVILLE, Calif., May 7, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health ... | |
| Buy rating | 11/25/20 |
| Jefferies initiates coverage with Buy rating and announces Price Target of $3.35 | |
| Buy rating | 11/25/20 |
| Cowen & Co. initiates coverage with Market Perform rating and announces Price Target of $5.00 | |
| Date | 2020-11-05 (BMO) | Est. (EPS/Rev.) | ($0.17)/ 38.76M |
| Actual (EPS/Rev.) | $-0.18/ $34.26 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| WaveCrest - Pascal(tm) Earnings Picks | WaveCrest | 50.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
